Fitlife Brands, Inc. FTLF
We take great care to ensure that the data presented and summarized in this overview for FITLIFE BRANDS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in FTLF
Top Purchases
Top Sells
About FTLF
FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for professional muscular development; weight loss and sports nutrition performance enhancing supplements for fitness enthusiasts; and men's health and weight loss formulations, as well as other diet, health, and sports nutrition supplements and related products; and sports nutritional products, energy and weight loss products, and meal replacements. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize through franchised stores, as well as through various retail locations, including specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.
Insider Transactions at FTLF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Jan 15
2025
|
Todd Ordal |
BUY
Open market or private purchase
|
Direct |
150
+0.48%
|
$4,500
$30.37 P/Share
|
|
Dec 30
2024
|
Judd Dayton CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,200
+1.38%
|
$0
$0.7 P/Share
|
|
Jun 03
2024
|
Patrick John Phillip Ryan CHIEF RETAIL OFFICER |
SELL
Open market or private sale
|
Direct |
6,544
-80.56%
|
$209,408
$32.15 P/Share
|
|
May 31
2024
|
Patrick John Phillip Ryan CHIEF RETAIL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-37.94%
|
$124,000
$31.0 P/Share
|
|
Dec 28
2023
|
Judd Dayton CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,600
+1.93%
|
$0
$0.7 P/Share
|
|
Dec 15
2023
|
Patrick John Phillip Ryan CHIEF RETAIL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-27.5%
|
$96,000
$24.5 P/Share
|
|
Oct 04
2023
|
Judd Dayton CHIEF EXECUTIVE OFFICER |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
143,480
+6.49%
|
$143,480
$1.15 P/Share
|
|
May 18
2023
|
Jakob York CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
1,000
+22.3%
|
$17,000
$17.0 P/Share
|
|
Dec 30
2021
|
Judd Dayton CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,275
-0.49%
|
$36,400
$16.0 P/Share
|
|
Dec 30
2021
|
Judd Dayton CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
52,000
+10.13%
|
$0
$0.7 P/Share
|
|
Apr 19
2021
|
Todd Ordal |
SELL
Open market or private sale
|
Direct |
9,023
-53.84%
|
$252,644
$28.5 P/Share
|
|
Feb 05
2021
|
Judd Dayton CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+28.12%
|
-
|
|
Dec 31
2020
|
Todd Ordal |
BUY
Grant, award, or other acquisition
|
Direct |
174
+1.03%
|
$3,654
$21.6 P/Share
|
|
Oct 16
2020
|
Judd Dayton CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Indirect |
14,431
+2.91%
|
$187,603
$13.5 P/Share
|
|
Oct 16
2020
|
Lewis Jaffe |
SELL
Open market or private sale
|
Direct |
14,431
-100.0%
|
$187,603
$13.5 P/Share
|
|
Sep 30
2020
|
Todd Ordal |
BUY
Grant, award, or other acquisition
|
Direct |
255
+1.51%
|
$3,570
$14.75 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 150 shares |
|---|---|
| Exercise of conversion of derivative security | 6.2K shares |
| Open market or private sale | 10.5K shares |
|---|